Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 117 entries
View as:

A Study to Evaluate the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT03896581 Org: User:
Start: 03/28/19 End: 02/14/22 Due: 02/14/23

A Single-ascending Dose (Part A) and Repeat-dose (Part B) Study to Investigate the Safety, Pharmacokinetics and Efficacy (Part B Only) of UCB1381 in Healthy Study Participants (Part A) and in Study Participants With Moderate to Severe Atopic Dermatitis (Part B)

Phase: N/A Priority: Normal
NCT ID: NCT05277571 Org: User:
Start: 03/07/22 End: 09/22/25 Due: 09/22/26

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa

Phase: N/A Priority: Normal
NCT ID: NCT04242446 Org: User:
Start: 02/19/20 End: 02/19/23 Due: 02/19/24

A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures

Phase: N/A Priority: Normal
NCT ID: NCT05076617 Org: User:
Start: 02/03/22 End: 11/30/28 Due: 11/30/29

A Study to Test the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT03895203 Org: User:
Start: 04/03/19 End: 07/11/22 Due: 07/11/23

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa

Phase: N/A Priority: Normal
NCT ID: NCT04242498 Org: User:
Start: 03/02/20 End: 09/28/22 Due: 09/28/23

A Study to Assess Long-term Safety, Tolerability and Efficacy of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Phase: N/A Priority: Normal
NCT ID: NCT04051944 Org: User:
Start: 08/21/19 End: 11/10/21 Due: 11/10/22

A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Subjects With Active Axial Spondyloarthritis Including Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis

Phase: N/A Priority: Normal
NCT ID: NCT04436640 Org: User:
Start: 06/16/20 End: 08/07/26 Due: 08/07/27

A Study to Test the Long-term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa

Phase: N/A Priority: Normal
NCT ID: NCT04901195 Org: User:
Start: 05/27/21 End: 07/28/26 Due: 07/28/27

An Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizumab in Pediatric Study Participants With Generalized Myasthenia Gravis

Phase: N/A Priority: Normal
NCT ID: NCT06540144 Org: User:
Start: 10/08/24 End: 08/17/27 Due: 08/17/28

A Study to Test the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Patients With Mild Cognitive Impairment or Mild Alzheimer's Disease (AD)

Phase: N/A Priority: Normal
NCT ID: NCT04867616 Org: User:
Start: 06/09/21 End: 07/28/25 Due: 07/28/26

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Study Participants With Active Psoriatic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT06624228 Org: User:
Start: 10/21/24 End: 07/08/26 Due: 07/08/27

A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures

Phase: N/A Priority: Normal
NCT ID: NCT05077904 Org: User:
Start: 12/07/21 End: 04/06/26 Due: 04/06/27

A Study to Assess the Pulmonary Safety of Staccato Alprazolam in Healthy Study Participants and in Study Participants With Mild Asthma

Phase: N/A Priority: Normal
NCT ID: NCT04802746 Org: User:
Start: 03/09/21 End: 11/22/21 Due: 11/22/22

A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT03370133 Org: User:
Start: 12/06/17 End: 12/13/19 Due: 12/13/20

A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT06315322 Org: User:
Start: 07/10/24 End: 03/01/30 Due: 03/01/31

A Proof-of-concept Study to Evaluate the Efficacy and Safety of Rozanolixizumab to Treat Adult Study Participants With Severe Fibromyalgia Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT05643794 Org: User:
Start: 12/21/22 End: 07/09/24 Due: 07/09/25

A Safety and Pharmacokinetics Study of UCB7853 in Healthy Study Participants and Study Participants With Parkinson's Disease (PD)

Phase: N/A Priority: Normal
NCT ID: NCT04651153 Org: User:
Start: 12/14/20 End: 07/20/23 Due: 07/20/24

A Study to Test the Efficacy and Safety of Bimekizumab and Certolizumab Pegol in Patients With Active Ankylosing Spondylitis

Phase: N/A Priority: Normal
NCT ID: NCT03215277 Org: User:
Start: 10/04/17 End: 05/25/20 Due: 05/25/21

A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)

Phase: N/A Priority: Normal
NCT ID: NCT04596995 Org: User:
Start: 01/06/21 End: 12/21/22 Due: 12/21/23

A Study to Assess the Safety and Tolerability, and Pharmacokinetics of UCB0022 in Healthy Caucasian, Japanese, and Chinese Participants

Phase: N/A Priority: Normal
NCT ID: NCT06970301 Org: User:
Start: 04/28/25 End: 10/31/25 Due: 10/31/26

A 18-month Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Oral UCB0599 in Study Participants With Early-stage Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT04658186 Org: User:
Start: 12/30/20 End: 09/06/24 Due: 09/06/25

A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis

Phase: N/A Priority: Normal
NCT ID: NCT03971422 Org: User:
Start: 06/03/19 End: 10/26/21 Due: 10/26/22

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT03598790 Org: User:
Start: 09/05/18 End: 11/14/23 Due: 11/14/24

A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis

Phase: N/A Priority: Normal
NCT ID: NCT06055959 Org: User:
Start: 10/16/24 End: 12/25/26 Due: 12/25/27